Fairholme's Berkowitz and Pfizer's Kindler - Conference Call This Monday
Fairholme Capital Management is hosting a call with the CEO of Pfizer on Monday. Here is the announcement:
Pfizer CEO Jeffrey Kindler will join Bruce Berkowitz, Fairholme Capital Management's Chief Investment Officer, for Conversations with Bruce on Monday, March 30th, from 3:00 to 4:00 PM Eastern Time. Charles Fernandez, President of Fairholme and an authority on restructurings and healthcare, will also join the discussion.
Before Jeff updates us on Pfizer's overall progress and the Wyeth merger, Bruce will quickly update you on Fairholme's portfolio of cash generating companies in today's tough times and then answer why Pfizer is now Fairholme's largest holding.
If you have questions about Pfizer, please submit them to agustin@fairholme.net in advance of the call. Jeff will answer the ten toughest questions submitted before we open the call to participants.
We hope that this and future conversations with managers of portfolio companies will lead to a better understanding of our companies and our firm. For details to participate in the call, visit www.fairholmefunds.com